The Patent Finder

Terms ending in 2033

Rhodes Technologies

Every in-force patent on Rhodes Technologies's record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 10,202,396Process for Improved Opioid Synthesis
In force
 · High confidence
Knoa Pharma LLCIn forceHigh confidence
US 11,390,627Process for Improved Opioid Synthesis
In force
 · High confidence
Knoa Pharma LLCIn forceHigh confidence
US 9,315,5141,3-Dioxanomorphides and 1,3-Dioxanocodides
In force
 · High confidence
Noramco, LLCIn forceHigh confidence
US 10,316,042Process for Improved Opioid Synthesis
In force
 · High confidence
Knoa Pharma LLCIn forceHigh confidence
US 9,834,5627 beta-Substituted 6a,14a-Ethenomorphinans and 7beta-Substituted 6a,14a-Ethanomorphinans
In force
 · High confidence
Knoa Pharma LLCIn forceHigh confidence
US 10,624,859Systems and Methods for Increasing Stability of Dronabinol Compositions
In force
 · High confidence
Rhodes TechnologiesIn forceHigh confidence
6 of 6 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Rhodes Technologies.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited